The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition.

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

International study looked at 800 patients in 37 countries Patients getting the drug saw less inflammation and fat in their livers Lead researcher says it could help treat liver disease like MASH ...

In a major clinical trial, the weight loss drug Wegovy has been able to treat a serious form of liver disease in the majority ...